178933-83-0 Usage
Uses
Used in Pharmaceutical Industry:
Tert-Butyl 2,5-dibromopentanoate is used as a synthetic intermediate for the development of various pharmaceuticals. Its unique chemical structure allows it to be a key component in the creation of new drugs, contributing to the advancement of medicinal chemistry.
Used in Agrochemical Industry:
In the agrochemical sector, Tert-Butyl 2,5-dibromopentanoate is employed as a precursor in the synthesis of agrochemicals. Its role in the production of these chemicals aids in the development of effective solutions for agricultural applications, such as pest control and crop protection.
Used in Organic Synthesis:
Tert-Butyl 2,5-dibromopentanoate is utilized as a reagent in organic synthesis, enabling the formation of esters and other organic compounds. Its versatility in chemical reactions makes it a valuable asset in the synthesis of a wide range of organic molecules.
Used in Chemical Reactions:
As a reagent in various chemical reactions, Tert-Butyl 2,5-dibromopentanoate is instrumental in facilitating the formation of new compounds and contributing to the advancement of chemical research and development. Its reactivity and properties make it a useful component in a variety of chemical processes.
Check Digit Verification of cas no
The CAS Registry Mumber 178933-83-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,8,9,3 and 3 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 178933-83:
(8*1)+(7*7)+(6*8)+(5*9)+(4*3)+(3*3)+(2*8)+(1*3)=190
190 % 10 = 0
So 178933-83-0 is a valid CAS Registry Number.
178933-83-0Relevant articles and documents
Method of preparing bicyclic intermediates from piperazic acid or an ester thereof useful in the manufacture of caspase inhibitors
-
Page column 11-12, (2010/02/05)
The invention relates to a process for synthesizing piperazic acid and similar, ring-containing acids. The invention also relates to a process for simultaneously N(2)-acylating piperazic acid or an ester thereof and forming a bicyclic ring structure. The invention also relates to the use of either or both processes in a method of synthesizing a bicyclic compound useful as an intermediate for the production of an inhibitor of a caspase, particularly an inhibitor of interleukin-1β converting enzyme (“ICE”).
